BACKGROUND: Prospective studies have reported associations among various markers of inflammation and the incidence of diabetes, and it has been proposed that inflammation has a causal role in the development of diabetes. The objective of this study was to investigate the significance of serum and urine neuraminidase activity (NA) and serum and urine sialic acid (SA) level in patients with Diabetic nephropathy. METHODS: In a prospective study, 190 diabetic patients with established diabetic nephropathy, 30 type 2 diabetes patients without any diabetic related nephropathy, and 36 non-diabetic patients with diagnosed nephropathy were enrolled. Two hundred and forty healthy individuals without diabetes or kidney disease were also enrolled as control group. Fasting venous blood samples and urine samples were collected and checked for serum and urine NA and SA level. RESULTS: In the diabetic nephropathy group, the mean value of serum and urine NA was 64.6 ± 2.6 and 11.7 ± 1.2 mU/ml, respectively, and mean values of serum and urine SA were 93.2 ± 3.6 and 17.7 ± 1.4 mg/dl, respectively. Serum and urine NA and SA levels were significantly higher in patient with diabetic nephropathy when compared to the other groups (P < 0.001). CONCLUSIONS: Our study suggests that there is a strong association between elevated serum and urine NA and serum and urine SA levels with the presence of diabetic nephropathy in type 2 diabetic patients. Further investigations are needed on the diagnostic and prognostic significance of these two inflammatory markers.
BACKGROUND: Prospective studies have reported associations among various markers of inflammation and the incidence of diabetes, and it has been proposed that inflammation has a causal role in the development of diabetes. The objective of this study was to investigate the significance of serum and urine neuraminidase activity (NA) and serum and urine sialic acid (SA) level in patients with Diabetic nephropathy. METHODS: In a prospective study, 190 diabeticpatients with established diabetic nephropathy, 30 type 2 diabetespatients without any diabetic related nephropathy, and 36 non-diabeticpatients with diagnosed nephropathy were enrolled. Two hundred and forty healthy individuals without diabetes or kidney disease were also enrolled as control group. Fasting venous blood samples and urine samples were collected and checked for serum and urine NA and SA level. RESULTS: In the diabetic nephropathy group, the mean value of serum and urine NA was 64.6 ± 2.6 and 11.7 ± 1.2 mU/ml, respectively, and mean values of serum and urine SA were 93.2 ± 3.6 and 17.7 ± 1.4 mg/dl, respectively. Serum and urine NA and SA levels were significantly higher in patient with diabetic nephropathy when compared to the other groups (P < 0.001). CONCLUSIONS: Our study suggests that there is a strong association between elevated serum and urine NA and serum and urine SA levels with the presence of diabetic nephropathy in type 2 diabeticpatients. Further investigations are needed on the diagnostic and prognostic significance of these two inflammatory markers.
Authors: K Taniuchi; K Chifu; N Hayashi; Y Nakamachi; N Yamaguchi; Y Miyamoto; K Doi; S Baba; Y Uchida; Y Tsukada; T Sugimori Journal: Kobe J Med Sci Date: 1981-06
Authors: Mingzhu Nie; Manjot S Bal; Zhufeng Yang; Jie Liu; Carolina Rivera; Andrea Wenzel; Bodo B Beck; Khashayar Sakhaee; Denise K Marciano; Matthias T F Wolf Journal: J Am Soc Nephrol Date: 2016-04-01 Impact factor: 10.121
Authors: Maik Pietzner; Anne Kaul; Ann-Kristin Henning; Gabi Kastenmüller; Anna Artati; Markus M Lerch; Jerzy Adamski; Matthias Nauck; Nele Friedrich Journal: BMC Med Date: 2017-11-30 Impact factor: 8.775
Authors: Christopher A Foote; Jorge A Castorena-Gonzalez; Francisco I Ramirez-Perez; Guanghong Jia; Michael A Hill; Constantino C Reyes-Aldasoro; James R Sowers; Luis A Martinez-Lemus Journal: Front Physiol Date: 2016-07-07 Impact factor: 4.566